SPI Earns Silver Medal for the second consecutive year in EcoVadis Sustainability Assessment

Summit Pharmaceuticals International Corporation (headquartered in Chiyoda-ku, Tokyo; Katsuya Okuyama, President & CEO; hereinafter “SPI”) has been awarded a Silver Medal (within the top 15%) for the second consecutive year in the 2025 Sustainability Assessment provided by EcoVadis. As a result of various improvement measures since the previous evaluation, SPI’s overall score has increased, leading to this recognition.

EcoVadis is an international organization that evaluates sustainability performances of more than 130,000 companies in 180 countries and their supply chains using its unique platform in four categories: environment, labor and human rights, ethics, and sustainable procurement.

To contribute to the realization of a sustainable society, SPI solves social issues through its business activities and engages in ongoing sustainability promotion activities.

About EcoVadis: https://ecovadis.com/

[Contact]
Summit Pharmaceuticals International Corporation
Business Administration Dept. Corporate Planning Group
Tel：+81-3-5220-1500
Email：2b-b@summitpharma.co.jp